Laurion Capital Management LP Kal Vista Pharmaceuticals, Inc. Transaction History

Laurion Capital Management LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$6.3 - $8.39 $514,281 - $684,892	-81,632 Reduced 82.44%	17,383 $136,000
Q4 2022 Feb 14, 2023	SELL	$4.2 - $14.24 $1.04 Million - $3.53 Million	-248,110 Reduced 71.48%	99,015 $669,000
Q3 2022 Nov 14, 2022	SELL	$9.85 - $16.83 $1.21 Million - $2.07 Million	-122,875 Reduced 26.14%	347,125 $5.04 Million
Q4 2021 Feb 14, 2022	BUY	$12.36 - $18.28 $4.33 Million - $6.4 Million	350,000 Added 291.67%	470,000 $6.22 Million
Q1 2021 May 14, 2021	BUY	$14.69 - $42.57 $1.76 Million - $5.11 Million	120,000 New	120,000 $3.08 Million
Q2 2019 Aug 13, 2019	SELL	$18.44 - $30.89 $1.09 Million - $1.82 Million	-58,871 Closed	0 $0
Q1 2019 May 08, 2019	BUY	$16.51 - $31.1 $473,341 - $891,637	28,670 Added 94.93%	58,871 $1.69 Million
Q4 2018 Feb 14, 2019	BUY	$16.21 - $24.06 $489,558 - $726,636	30,201 New	30,201 $596,000

125

47.8M

551K

110K

Ticker KALV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,602,000
Market Cap $250M
Description
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.